ITMCTR1900002544尚未招募未知
Case-series study for experience in the treatment of Chronic atrophic gastritis with four Illustrious Senior Traditional Chinese Medicine in Beijing
Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 性别
- All
入选标准
- •1. Patients with Chronic atrophic gastritis diagnosed by gastroscopy and pathohistology;
- •2. Patients voluntarily signed informed consent;
- •3. Patients who participated in three diagnosis and treatment and follow-up.
排除标准
- •1. Patients with peptic ulcer, gastroesophageal reflux disease, gastric polyp, pathological diagnosis suspected of malignant transformation and gastric surgery;
- •2. Patients with serious diseases such as heart, brain, liver, kidney and hematopoietic system;
- •3. Patients with severe mental illness, such as schizophrenia, depression, anxiety, etc.;
- •4. Pregnant or lactating women;
- •5. Unclear description or investigation of self-symptoms.
研究者
相似试验
尚未招募
不适用
Case-series study of experience in the treatment of ulcerative colitis with Three Illustrious Senior Traditional Chinese Medicine Doctors in Beijingulcerative colitisITMCTR1900002542Beijing University of Chinese Medicine
尚未招募
不适用
Retrospective study on the treatment of patients in specialized outpatient pain therapyChronic PainDRKS00031186Charité - Universitätsmedizin Berlin3,000
已完成
不适用
Cohort study for investigating treatment reality in resectable and unresectable stage III non-small-cell lung carcinoma populations in Japan (SOLUTION study)Stage III non-small cell lung cancerJPRN-UMIN000031385AstraZeneca K.K1,000
已完成
不适用
Observational study for treatment outcome in patients with HER2-positive metastatic breast cancer who received pertuzumab combination chemotherapy.Breast cancerJPRN-UMIN000012210Kurume University Hospital10
已完成
不适用
Clinical study using samples of patients experienced systemic side effects by vaccinessystemic side effects by vaccinesJPRN-UMIN000013052ational Institutes of Biomedical Innovation,Health and Nutrition2
